| Financial Year |
March 31 2023 |
| Monetary Funds |
236,044,338.45 |
| Held-for-trading Financial Assets |
171,809,013.89 |
| Notes Receivable |
13,837,500.00 |
| Accounts Receivable |
201,853,920.23 |
| Advances to Suppliers |
6,046,341.95 |
| Other Receivables |
39,754,556.52 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
260,799,038.63 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
31,953,030.79 |
| Total Current Assets |
970,681,199.81 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
10,092,076.19 |
| Fixed Assetes |
649,761,373.17 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
95,142,179.96 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
9,521,381.83 |
| Deferred Income Tax Assets |
48,363,187.19 |
| Other Non-Current Assets |
441,746.10 |
| Sub-Total of Non-Current Assets |
833,711,152.42 |
| Total Assets |
1,804,392,352.23 |
| Short-Term Loans |
160,250,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
120,696,363.07 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
19,556,831.56 |
| Taxes Payable |
16,146,433.38 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
8,455,084.33 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,274,781.73 |
| Other Current Liabilities |
1,147,971.80 |
| Sub-Total of Current Liabilities |
423,117,731.98 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,055,241.26 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
78,686,469.03 |
| Total Liabilities |
501,804,201.01 |
| Paid-In Capital(Or Share Stock) |
411,499,000.00 |
| Capital Surplus |
350,463,204.76 |
| Surplus Reserve |
95,561,876.23 |
| LESS:Treasury Stock |
11,924,693.02 |
| Undistributed Profits |
454,225,819.46 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,302,588,151.22 |
| Owner's Equity（Stockholder's Equity） |
1,302,588,151.22 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,804,392,352.23 |
